Clinical Trial Update: Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer [NA]

View source ↗

Summary

A clinical trial investigating photodynamic therapy with temoporfin before surgery for recurrent oral cavity and oropharyngeal cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma
• Tongue Cancer
• Verrucous Carcinoma of the Oral Cavity

Drugs mentioned

• Foscan (temoporfin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx | NA | Status: WITHDRAWN